{"id":37803,"date":"2017-02-13T10:05:53","date_gmt":"2017-02-13T15:05:53","guid":{"rendered":"https:\/\/cablemanpro.com\/wallstreetpr\/?p=37803"},"modified":"2017-02-13T10:05:53","modified_gmt":"2017-02-13T15:05:53","slug":"cannabics-pharmaceuticals-inc-otcmktscnbx-updates-on-commercialization-of-cbd-personalized-diagnostics","status":"publish","type":"post","link":"https:\/\/cablemanpro.com\/wallstreetpr\/cannabics-pharmaceuticals-inc-otcmktscnbx-updates-on-commercialization-of-cbd-personalized-diagnostics-37803","title":{"rendered":"Cannabics Pharmaceuticals Inc (OTCMKTS:CNBX) Updates On Commercialization Of CBD Personalized Diagnostics"},"content":{"rendered":"<p style=\"text-align: justify;\"><strong>Cannabics Pharmaceuticals Inc (OTCMKTS:CNBX)<\/strong> will launch personalized CBD anti-tumor tests for people suffering with cancer. The diagnostic tests use liquid biopsies of cancer patients. It uses CTC technology that accumulates cancer cells from cancer patients&#8217; blood samples, and assesses their sensitivity to CBD compounds together with conventional chemotherapy drug.<\/p>\n<h2 style=\"text-align: justify;\"><strong>The details<\/strong><\/h2>\n<p style=\"text-align: justify;\">The study data allow physicians to better plan their decisions as they can personalize patient data and support evidence to prevailing market treatments. Dr. Eyal Ballan, who is the Chief scientist of Cannabics, reported that they intend to make use of the natural medicinal properties of cannabis. This will be achieved using the diversity of active composites to fight cancer in its demonstration in each individual patient.<\/p>\n<p style=\"text-align: justify;\">Through an exclusive assignment with Cancer Hope Israel, which focuses on providing a comprehensive check of the chemotherapy and unique biological drug\u2019s effectiveness, Cannabics will provide its patented cannabinoid based compounds to be tested in their anti-tumor properties. The company plans to start commercialization process in March, when 10 initial patients&#8217; liquid biopsies will be assessed deploying this technology.<\/p>\n<p style=\"text-align: justify;\">Cannabics objective is to spread this service to cancer patients across Canada, Europe and the U.S., under resident medical cannabis protocols in each country and state. This target has to be achieved by the close of the year. Itamar Borochov, the CEO, commented that they mark the first firm in the world to offer personalized CBD anti-tumor diagnostics to cancer patients. The company is excited to be pioneers in the segment of cannabis and personalized cancer therapies.<\/p>\n<p style=\"text-align: justify;\">Cancer Hope Israel comes in the list of a Personalized Oncology Center that shows and provides state-of-the-art diagnostics for personalized cancer treatment. Cancer Hope collaborates with international leaders in cancer diagnostics and medicinal solutions in endeavor to promote personalized oncology therapy as standard treatment. As part of their vision they intend to bring together oncology experts with latest diagnostics for best patient care.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Cannabics Pharmaceuticals Inc (OTCMKTS:CNBX) will launch personalized CBD anti-tumor tests for people suffering with cancer. The diagnostic tests use liquid biopsies of cancer patients. It [&hellip;]<\/p>\n","protected":false},"author":2,"featured_media":37804,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"rop_custom_images_group":[],"rop_custom_messages_group":[],"rop_publish_now":"initial","rop_publish_now_accounts":{"twitter_2902945987_2902945987":""},"rop_publish_now_history":[],"rop_publish_now_status":"pending","footnotes":""},"categories":[264],"tags":[12277,12275,12278,12276],"stock_ticker":[],"class_list":["post-37803","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-health","tag-cannabics-pharmaceuticals-inc","tag-cannabics-pharmaceuticals-inc-otcmktscnbx","tag-itamar-borochov","tag-otcmktscnbx","entry"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v26.9 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Cannabics Pharmaceuticals Inc (OTCMKTS:CNBX) Updates On Commercialization Of CBD Personalized Diagnostics - Wall Street PR<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/cablemanpro.com\/wallstreetpr\/cannabics-pharmaceuticals-inc-otcmktscnbx-updates-on-commercialization-of-cbd-personalized-diagnostics-37803\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Cannabics Pharmaceuticals Inc (OTCMKTS:CNBX) Updates On Commercialization Of CBD Personalized Diagnostics - Wall Street PR\" \/>\n<meta property=\"og:description\" content=\"Cannabics Pharmaceuticals Inc (OTCMKTS:CNBX) will launch personalized CBD anti-tumor tests for people suffering with cancer. The diagnostic tests use liquid biopsies of cancer patients. It [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/cablemanpro.com\/wallstreetpr\/cannabics-pharmaceuticals-inc-otcmktscnbx-updates-on-commercialization-of-cbd-personalized-diagnostics-37803\" \/>\n<meta property=\"og:site_name\" content=\"Wall Street PR\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/WallStreetPR\/\" \/>\n<meta property=\"article:published_time\" content=\"2017-02-13T15:05:53+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2017\/02\/Cannabics-Pharmaceuticals-Inc.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"900\" \/>\n\t<meta property=\"og:image:height\" content=\"900\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Donna Fago\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Donna Fago\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/cannabics-pharmaceuticals-inc-otcmktscnbx-updates-on-commercialization-of-cbd-personalized-diagnostics-37803#article\",\"isPartOf\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/cannabics-pharmaceuticals-inc-otcmktscnbx-updates-on-commercialization-of-cbd-personalized-diagnostics-37803\"},\"author\":{\"name\":\"Donna Fago\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/person\/60ece280249b1fa366ae54f87bb8ae84\"},\"headline\":\"Cannabics Pharmaceuticals Inc (OTCMKTS:CNBX) Updates On Commercialization Of CBD Personalized Diagnostics\",\"datePublished\":\"2017-02-13T15:05:53+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/cannabics-pharmaceuticals-inc-otcmktscnbx-updates-on-commercialization-of-cbd-personalized-diagnostics-37803\"},\"wordCount\":331,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#organization\"},\"image\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/cannabics-pharmaceuticals-inc-otcmktscnbx-updates-on-commercialization-of-cbd-personalized-diagnostics-37803#primaryimage\"},\"thumbnailUrl\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2017\/02\/Cannabics-Pharmaceuticals-Inc.jpg\",\"keywords\":[\"Cannabics Pharmaceuticals Inc\",\"Cannabics Pharmaceuticals Inc (OTCMKTS:CNBX)\",\"Itamar Borochov\",\"OTCMKTS:CNBX\"],\"articleSection\":[\"Health\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/cablemanpro.com\/wallstreetpr\/cannabics-pharmaceuticals-inc-otcmktscnbx-updates-on-commercialization-of-cbd-personalized-diagnostics-37803#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/cannabics-pharmaceuticals-inc-otcmktscnbx-updates-on-commercialization-of-cbd-personalized-diagnostics-37803\",\"url\":\"https:\/\/cablemanpro.com\/wallstreetpr\/cannabics-pharmaceuticals-inc-otcmktscnbx-updates-on-commercialization-of-cbd-personalized-diagnostics-37803\",\"name\":\"Cannabics Pharmaceuticals Inc (OTCMKTS:CNBX) Updates On Commercialization Of CBD Personalized Diagnostics - Wall Street PR\",\"isPartOf\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/cannabics-pharmaceuticals-inc-otcmktscnbx-updates-on-commercialization-of-cbd-personalized-diagnostics-37803#primaryimage\"},\"image\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/cannabics-pharmaceuticals-inc-otcmktscnbx-updates-on-commercialization-of-cbd-personalized-diagnostics-37803#primaryimage\"},\"thumbnailUrl\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2017\/02\/Cannabics-Pharmaceuticals-Inc.jpg\",\"datePublished\":\"2017-02-13T15:05:53+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/cannabics-pharmaceuticals-inc-otcmktscnbx-updates-on-commercialization-of-cbd-personalized-diagnostics-37803#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/cablemanpro.com\/wallstreetpr\/cannabics-pharmaceuticals-inc-otcmktscnbx-updates-on-commercialization-of-cbd-personalized-diagnostics-37803\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/cannabics-pharmaceuticals-inc-otcmktscnbx-updates-on-commercialization-of-cbd-personalized-diagnostics-37803#primaryimage\",\"url\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2017\/02\/Cannabics-Pharmaceuticals-Inc.jpg\",\"contentUrl\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2017\/02\/Cannabics-Pharmaceuticals-Inc.jpg\",\"width\":900,\"height\":900,\"caption\":\"Cannabics Pharmaceuticals Inc\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/cannabics-pharmaceuticals-inc-otcmktscnbx-updates-on-commercialization-of-cbd-personalized-diagnostics-37803#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/cablemanpro.com\/wallstreetpr\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Cannabics Pharmaceuticals Inc (OTCMKTS:CNBX) Updates On Commercialization Of CBD Personalized Diagnostics\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#website\",\"url\":\"https:\/\/cablemanpro.com\/wallstreetpr\/\",\"name\":\"Wall Street PR\",\"description\":\"Latest News From WallStreet\",\"publisher\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/cablemanpro.com\/wallstreetpr\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#organization\",\"name\":\"Wall Street PR\",\"url\":\"https:\/\/cablemanpro.com\/wallstreetpr\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2019\/10\/brand-logo.png\",\"contentUrl\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2019\/10\/brand-logo.png\",\"width\":537,\"height\":70,\"caption\":\"Wall Street PR\"},\"image\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.facebook.com\/WallStreetPR\/\",\"https:\/\/x.com\/WallstreetPRs\"]},{\"@type\":\"Person\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/person\/60ece280249b1fa366ae54f87bb8ae84\",\"name\":\"Donna Fago\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2019\/06\/f15db860f556e28a86f628554c98485b.jpeg\",\"contentUrl\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2019\/06\/f15db860f556e28a86f628554c98485b.jpeg\",\"caption\":\"Donna Fago\"},\"description\":\"I believe in writing content Informing investors with the knowledge they need to invest better today- I have been following the markets for many years and was asked to join the team at WallStreetPR.com recently due to my passion for the markets.\",\"sameAs\":[\"http:\/\/www.WallStreetPR.com\"],\"url\":\"https:\/\/cablemanpro.com\/wallstreetpr\/author\/darcie-fago\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Cannabics Pharmaceuticals Inc (OTCMKTS:CNBX) Updates On Commercialization Of CBD Personalized Diagnostics - Wall Street PR","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/cablemanpro.com\/wallstreetpr\/cannabics-pharmaceuticals-inc-otcmktscnbx-updates-on-commercialization-of-cbd-personalized-diagnostics-37803","og_locale":"en_US","og_type":"article","og_title":"Cannabics Pharmaceuticals Inc (OTCMKTS:CNBX) Updates On Commercialization Of CBD Personalized Diagnostics - Wall Street PR","og_description":"Cannabics Pharmaceuticals Inc (OTCMKTS:CNBX) will launch personalized CBD anti-tumor tests for people suffering with cancer. The diagnostic tests use liquid biopsies of cancer patients. It [&hellip;]","og_url":"https:\/\/cablemanpro.com\/wallstreetpr\/cannabics-pharmaceuticals-inc-otcmktscnbx-updates-on-commercialization-of-cbd-personalized-diagnostics-37803","og_site_name":"Wall Street PR","article_publisher":"https:\/\/www.facebook.com\/WallStreetPR\/","article_published_time":"2017-02-13T15:05:53+00:00","og_image":[{"width":900,"height":900,"url":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2017\/02\/Cannabics-Pharmaceuticals-Inc.jpg","type":"image\/jpeg"}],"author":"Donna Fago","twitter_misc":{"Written by":"Donna Fago","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/cannabics-pharmaceuticals-inc-otcmktscnbx-updates-on-commercialization-of-cbd-personalized-diagnostics-37803#article","isPartOf":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/cannabics-pharmaceuticals-inc-otcmktscnbx-updates-on-commercialization-of-cbd-personalized-diagnostics-37803"},"author":{"name":"Donna Fago","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/person\/60ece280249b1fa366ae54f87bb8ae84"},"headline":"Cannabics Pharmaceuticals Inc (OTCMKTS:CNBX) Updates On Commercialization Of CBD Personalized Diagnostics","datePublished":"2017-02-13T15:05:53+00:00","mainEntityOfPage":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/cannabics-pharmaceuticals-inc-otcmktscnbx-updates-on-commercialization-of-cbd-personalized-diagnostics-37803"},"wordCount":331,"commentCount":0,"publisher":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#organization"},"image":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/cannabics-pharmaceuticals-inc-otcmktscnbx-updates-on-commercialization-of-cbd-personalized-diagnostics-37803#primaryimage"},"thumbnailUrl":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2017\/02\/Cannabics-Pharmaceuticals-Inc.jpg","keywords":["Cannabics Pharmaceuticals Inc","Cannabics Pharmaceuticals Inc (OTCMKTS:CNBX)","Itamar Borochov","OTCMKTS:CNBX"],"articleSection":["Health"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/cablemanpro.com\/wallstreetpr\/cannabics-pharmaceuticals-inc-otcmktscnbx-updates-on-commercialization-of-cbd-personalized-diagnostics-37803#respond"]}]},{"@type":"WebPage","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/cannabics-pharmaceuticals-inc-otcmktscnbx-updates-on-commercialization-of-cbd-personalized-diagnostics-37803","url":"https:\/\/cablemanpro.com\/wallstreetpr\/cannabics-pharmaceuticals-inc-otcmktscnbx-updates-on-commercialization-of-cbd-personalized-diagnostics-37803","name":"Cannabics Pharmaceuticals Inc (OTCMKTS:CNBX) Updates On Commercialization Of CBD Personalized Diagnostics - Wall Street PR","isPartOf":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#website"},"primaryImageOfPage":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/cannabics-pharmaceuticals-inc-otcmktscnbx-updates-on-commercialization-of-cbd-personalized-diagnostics-37803#primaryimage"},"image":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/cannabics-pharmaceuticals-inc-otcmktscnbx-updates-on-commercialization-of-cbd-personalized-diagnostics-37803#primaryimage"},"thumbnailUrl":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2017\/02\/Cannabics-Pharmaceuticals-Inc.jpg","datePublished":"2017-02-13T15:05:53+00:00","breadcrumb":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/cannabics-pharmaceuticals-inc-otcmktscnbx-updates-on-commercialization-of-cbd-personalized-diagnostics-37803#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/cablemanpro.com\/wallstreetpr\/cannabics-pharmaceuticals-inc-otcmktscnbx-updates-on-commercialization-of-cbd-personalized-diagnostics-37803"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/cannabics-pharmaceuticals-inc-otcmktscnbx-updates-on-commercialization-of-cbd-personalized-diagnostics-37803#primaryimage","url":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2017\/02\/Cannabics-Pharmaceuticals-Inc.jpg","contentUrl":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2017\/02\/Cannabics-Pharmaceuticals-Inc.jpg","width":900,"height":900,"caption":"Cannabics Pharmaceuticals Inc"},{"@type":"BreadcrumbList","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/cannabics-pharmaceuticals-inc-otcmktscnbx-updates-on-commercialization-of-cbd-personalized-diagnostics-37803#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/cablemanpro.com\/wallstreetpr\/"},{"@type":"ListItem","position":2,"name":"Cannabics Pharmaceuticals Inc (OTCMKTS:CNBX) Updates On Commercialization Of CBD Personalized Diagnostics"}]},{"@type":"WebSite","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#website","url":"https:\/\/cablemanpro.com\/wallstreetpr\/","name":"Wall Street PR","description":"Latest News From WallStreet","publisher":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/cablemanpro.com\/wallstreetpr\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#organization","name":"Wall Street PR","url":"https:\/\/cablemanpro.com\/wallstreetpr\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/logo\/image\/","url":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2019\/10\/brand-logo.png","contentUrl":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2019\/10\/brand-logo.png","width":537,"height":70,"caption":"Wall Street PR"},"image":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/WallStreetPR\/","https:\/\/x.com\/WallstreetPRs"]},{"@type":"Person","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/person\/60ece280249b1fa366ae54f87bb8ae84","name":"Donna Fago","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/person\/image\/","url":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2019\/06\/f15db860f556e28a86f628554c98485b.jpeg","contentUrl":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2019\/06\/f15db860f556e28a86f628554c98485b.jpeg","caption":"Donna Fago"},"description":"I believe in writing content Informing investors with the knowledge they need to invest better today- I have been following the markets for many years and was asked to join the team at WallStreetPR.com recently due to my passion for the markets.","sameAs":["http:\/\/www.WallStreetPR.com"],"url":"https:\/\/cablemanpro.com\/wallstreetpr\/author\/darcie-fago"}]}},"_links":{"self":[{"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/posts\/37803","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/comments?post=37803"}],"version-history":[{"count":0,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/posts\/37803\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/media\/37804"}],"wp:attachment":[{"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/media?parent=37803"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/categories?post=37803"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/tags?post=37803"},{"taxonomy":"stock_ticker","embeddable":true,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/stock_ticker?post=37803"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}